Canine mammary tumour cells exposure to sevoflurane: effects on cell proliferation and neuroepithelial transforming gene 1 expression

Published:February 06, 2019DOI:



      The influence of perioperative factors, such as anaesthetic and analgesic techniques, on metastatic spread following surgery for primary cancer removal is of growing interest. The present study investigated the effects of sevoflurane on canine mammary tumour cell proliferation (MTT colorimetric assay) and on the expression of neuroepithelial transforming gene 1 (NET1).

      Study design

      Prospective controlled in vitro trial.

      Study material

      Primary (CIPp) and metastatic canine tubular adenocarcinoma (CIPm) cells.


      To perform MTT tests, cell lines were seeded at a density of 3000 cells per well and incubated with sevoflurane (1, 2.5 or 4 mM) or only with the culture medium (control). Sevoflurane was added to the cell cultures every hour to avoid changes in drug concentration. MTT assays were performed after 6 hours of exposure obtaining absolute values of absorbance. The RNA isolated from the lysates of the same cell lines underwent quantitative polymerase chain reaction to evaluate NET1 gene expression changes compared with controls. One- or two-way analysis of variance was used as appropriate (p < 0.05).


      A significant increase in cell proliferation compared with controls was observed in CIPp treated with lower sevoflurane concentrations, whereas a significant decrease in cell proliferation was found in CIPm treated with all the sevoflurane concentrations. All CIPp treatments did not induce changes in gene expression compared with controls, whereas a significant increase in gene expression was observed in CIPm between controls and the higher sevoflurane concentration.

      Conclusions and clinical relevance

      Sevoflurane treatments modified the cell proliferation rate in both cell lines showing an increase or decrease when applied to CIPp or CIPm, respectively. Expression of the NET1 gene increased after treatment with sevoflurane 4 mM in metastatic cells. The role of sevoflurane on cancer recurrence should be further investigated.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Veterinary Anaesthesia and Analgesia
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Deegan C.A.
        • Murray D.
        • Doran P.
        • et al.
        Effect of anaesthetic technique on oestrogen receptor-negative breast cancer cell function in vitro.
        Br J Anaesth. 2009; 103: 685-690
        • Ecimovic P.
        • Mchugh B.
        • Murray D.
        • et al.
        Effects of sevoflurane on breast cancer cell function in vitro.
        Anticancer Res. 2013; 33: 4255-4260
        • Ecimovic P.
        • Murray D.
        • Doran P.P.
        • Buggy D.J.
        Propofol and bupivacaine in breast cancer cell function in vitro – Role of the NET1 gene.
        Anticancer Res. 2014; 34: 1321-1332
        • Karayannopoulou M.
        • Lafioniatis S.
        Recent advances on canine mammary cancer chemotherapy: A review of studies from 2000 to date.
        Revue Méd Vét. 2016; 167: 192-200
        • Leyden J.
        • Murray D.
        • Moss A.
        • et al.
        Net1 and Myeov : computationally identified mediators of gastric cancer.
        Br J Cancer. 2006; 94: 1204-1212
        • O'Leary G.
        • Bacon C.L.
        • Odumeru O.
        • et al.
        Antiproliferative actions of inhalational anesthetics: comparisons to the valproate teratogen.
        Int J Dev Neurosci. 2000; 18: 39-45
        • Tada H.
        • Shiho O.
        • Kuroshima K.
        • et al.
        An improved colorimetric assay for interleukin 2.
        J Immunol Meth. 1986; 9: 157-165
        • Uyama R.
        • Nakagawa T.
        • Hong S.H.
        • et al.
        Establishment of four pairs of canine mammary tumour cell lines derived from primary and metastatic origin and their E-cadherin expression.
        Vet Comp Oncol. 2006; 4: 104-113
        • Van Meerloo J.
        • Kaspers G.J.L.
        • Cloos J.
        Cell Sensitivity Assays: The MTT Assay.
        Meth Mol Biol. 2011; 731: 237-345
        • Vascellari M.
        • Capello K.
        • Carminato A.
        • et al.
        Incidence of mammary tumors in the canine population living in the Veneto region (Northeastern Italy): Risk factors and similarities to human breast cancer.
        Prev Vet Med. 2016; 126: 183-189
        • Wigmore T.J.
        • Mohammed K.
        • Jhanji S.
        Long-term survival for patients undergoing volatile versus IV anesthesia for cancer surgery.
        Anesthesiol. 2016; 124: 69-79